{"organizations": [], "uuid": "19510c72cabbce697dcc9bbb827437609367b3e0", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180123.html", "section_title": "Archive News &amp; Video for Tuesday, 23 Jan 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-luye-pharma-updates-on-development/brief-luye-pharma-updates-on-development-of-ansofaxine-hydrochloride-extended-release-tablets-idUSFWN1PI0OU", "country": "US", "domain_rank": 408, "title": "BRIEF-Luye Pharma ‍Updates On Development Of Ansofaxine Hydrochloride Extended Release Tablets​", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.923, "site_type": "news", "published": "2018-01-23T21:12:00.000+02:00", "replies_count": 0, "uuid": "19510c72cabbce697dcc9bbb827437609367b3e0"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-luye-pharma-updates-on-development/brief-luye-pharma-updates-on-development-of-ansofaxine-hydrochloride-extended-release-tablets-idUSFWN1PI0OU", "ord_in_thread": 0, "title": "BRIEF-Luye Pharma ‍Updates On Development Of Ansofaxine Hydrochloride Extended Release Tablets​", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters) - luye pharma group ltd", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Jan 23 (Reuters) - Luye Pharma Group Ltd:\n* ‍UPDATES ON PHASE II CLINICAL TRIAL IN CHINA FOR ANSOFAXINE HYDROCHLORIDE EXTENDED RELEASE TABLETS​\n* PRELIMINARY RESULTS OF PHASE II TRIAL MET PRIMARY EFFICACY ENDPOINT Source text for Eikon: Further company coverage:\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-01-23T21:12:00.000+02:00", "crawled": "2018-01-24T15:27:46.004+02:00", "highlightTitle": ""}